Bioquark Inc. has several additional, early stage Bioquantine programs in development.
Bioquantine – Complex (BQ-Complex) – focused on various areas of “higher order” regeneration and repair dynamics, and the novel biologic and biophysical components required to begin to address such complex cases.
Such programs will integrate Bioquantines with various supporting tools such as scaffolding technologies, bioreactors, and electroceutical technology to fully implement.
These programs include applications in both severe limb amputation and catastrophic wounding.
Bioquantine – DNA (BQ-DNA) – focused on the natural, endogenous gene and chromosomal correction dynamics found extensively throughout regenerative and embryonic tissue niches.
In-vivo reversion to normal of inherited mutations in humans will offer the possibility to address a wide range of genetic and chromosomal diseases.
Bioquantine – AntiViral (BQ-AV) – tapping into the novel mechanisms found in ooplasms and other regenerative micro-environments, for viral silencing, extinction, and symbiogenesis, evolutionarily perfected to protect developing embryos from infection and death.